WORK Medical Technology Group LTD WOK
- Market cap
- $8.9M
- P/E
- —
Follow WOK
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | 3,260,000.00 | 206.00 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | — | — | 8,446,000.00 | 6,000,000.00 |
High Price
|
|||
| — | — | — | — | — | — | — | 226 | 216 | 238 |
Employees
|
|||
| — | — | — | — | — | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | — | 20 | 20 | 14 | 12 | 10 |
Revenue
|
|||
| — | — | — | — | — | 22.42% | 22.42% | 30.54% | 24.93% | 23.81% |
Gross Margin
|
|||
| — | — | — | — | — | 1 | 1 | 0 | (4) | (1) |
EBT
|
|||
| — | — | — | — | — | 5.65% | 5.65% | 0.81% | (31.86%) | (10.99%) |
EBT Margin
|
|||
| — | — | — | — | — | 0 | 1 | 0 | (4) | (1) |
Net Income
|
|||
| — | — | — | — | — | — | 3 | 2 | 1 | 1 |
Depreciation
|
|||
| — | — | — | — | — | 0.00 | 1.58 | 1.09 | 90.53 | 33.98 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | 0.08 | 0.01 | (27.87) | (4.00) |
Earnings/Sh
|
|||
| — | — | — | — | — | — | (0.18) | 0.18 | (17.53) | 21.55 |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | (0.11) | (0.05) | (71.31) | (2.97) |
Capex/Sh
|
|||
| — | — | — | — | — | — | (0.29) | 0.13 | (88.84) | 18.58 |
Free CF/Sh
|
|||
| — | — | — | — | — | 0.00 | 0.90 | 0.88 | 126.44 | 73.03 |
Book Value/Sh
|
|||
| — | — | — | — | — | — | 13 | 13 | 0 | 0 |
Shares
|
|||
| — | — | — | — | — | — | — | — | — | — | PE Ratio | |||
| — | — | — | — | — | — | — | — | — | — | PS Ratio | |||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio
|
|||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales
|
|||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | (0.44) | (0.24) |
EV/FCF
|
|||
| — | — | — | — | — | — | (2) | 2 | (2) | 6 |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | (1) | (1) | (9) | (1) |
Capex
|
|||
| — | — | — | — | — | — | (4) | 2 | (11) | 5 |
FCF
|
|||
| — | — | — | — | — | 2 | 2 | 3 | 1 | 8 |
Working Cap'
|
|||
| — | — | — | — | — | — | 6 | 9 | 13 | 6 |
Total Debt
|
|||
| — | — | — | — | — | (1) | 5 | 7 | 6 | 2 |
Net Debt
|
|||
| — | — | — | — | — | 11 | 11 | 11 | 16 | 21 |
Sh' Equity
|
|||
| — | — | — | — | — | 0.00% | 3.39% | 0.40% | (10.55%) | (3.09%) |
ROA
|
|||
| — | — | — | — | — | 4.93% | 2.43% | 1.42% | (11.27%) | (6.65%) |
ROIC
|
|||
| — | — | — | — | — | 0.00% | 8.36% | 1.01% | (25.82%) | (5.76%) |
ROE
|
|||
WORK Medical Technology Group LTD peers in Medical Devices
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| CODX Co-Diagnostics, Inc. | $8.3M | 0.0× | Compare |
| AMIX Autonomix Medical, Inc. | $7.9M | 0.0× | Compare |
| AEMD Aethlon Medical, Inc. | $10.4M | 0.0× | Compare |
| BTCY Biotricity Inc. | $10.9M | 0.0× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| PMI Flag Ship Acquisition Corp | $11.1M | 0.2× | Compare |
| IRIX IRIDEX Corporation | $11.1M | 0.0× | Compare |
| BMRA Biomerica, Inc. | $11.3M | 0.0× | Compare |
| VNRX VolitionRX Limited | $6.9M | 0.0× | Compare |
WORK Medical Technology Group LTD (WOK) key facts
- WORK Medical Technology Group LTD (WOK) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
- WORK Medical Technology Group LTD’s revenue for fiscal 2025 (year ended September 2025) was $9.8 million, down 14.4% from fiscal 2024.
- WORK Medical Technology Group LTD reported a net loss of $1.2 million, or a loss of $4.00 per share, for fiscal 2025.
- As of September 25, 2026, WOK traded at $1.91, a market capitalization of $8.9 million.
- Return on equity was −5.76% and debt-to-equity 0.20.
WORK Medical Technology Group LTD (WOK) Latest News
3 Jun
WORK Medical Technology Group establishes U.S. subsidiary to advance global expansion and reinforce long-term growth strategy. U.S. subsidiary launch constitutes major strategic move with potential to significantly alter growth trajectory and market positioning.
13 May
WORK Medical Technology Group LTD (WOK) stock surged over 69% in after-hours trading, trending overnight due to undisclosed catalysts. A 69% after-hours surge reflects major positive developments likely to significantly boost investor sentiment and market performance.
11 May
WORK Medical Technology Group LTD (WOK) partners with AI Healthcare and BioToken to expand digital asset ambitions in healthcare. Partnership enables major strategic entry into AI-driven digital assets, altering WOK's competitive trajectory and investor appeal.
WORK Medical Technology Group LTD (WOK) partners with Novabioplus to apply AI in unlocking biological data value, advancing the 'BioToken' assetization model. Collaboration leverages AI for biological data assetization via BioToken, marking a major strategic advancement in WOK's biotech innovation and market positioning.
1 May
WORK Medical Technology Group LTD (WOK) deepens its Web3.0 strategic layout by co-authoring an asset tokenization whitepaper. Co-authoring a Web3.0 asset tokenization whitepaper represents a moderate strategic expansion into blockchain for a medical tech firm, potentially influencing innovation and investor sentiment without fundamental transformation.
29 Dec
WORK Medical Technology Group LTD has granted exclusive distribution rights for its AI-automated blood cell morphology analyzer in East China. The company has set a sales target of RMB10 million for the year 2026, indicating a strategic move to expand its market presence in the region and enhance its product offerings in medical technology. Granting exclusive distribution rights and setting a significant sales target indicates a major strategic move that could enhance market positioning and investor sentiment.
WORK Medical Technology Group LTD's subsidiary has received manufacturing approval for its AI-automated blood cell morphology analyzer, marking a significant advancement in their product offerings and potential market impact. The approval of a new AI-driven medical device is likely to significantly enhance the company's competitive position and market presence.
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in the market, indicating heightened trading activity and investor interest. This surge in activity may reflect broader market trends or specific developments related to the company, potentially influencing its stock performance and investor sentiment moving forward. Increased trading activity suggests a moderately noticeable influence on market sentiment and potential financial performance.
26 Dec
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in recent trading sessions, indicating heightened investor interest and trading volume. This activity may reflect market sentiment or reactions to recent developments within the company or its sector. Investors are closely monitoring WOK's performance as it navigates current market conditions. Increased trading activity suggests a moderate influence on market sentiment and potential financial performance.
24 Dec
WORK Medical Technology Group LTD announced a 1-for-100 reverse stock split effective December 29, 2025. This move is aimed at increasing the company's stock price and improving its marketability. The reverse split will reduce the number of outstanding shares, potentially enhancing shareholder value and attracting institutional investors. The reverse stock split may moderately influence market perception and stock performance but is not expected to fundamentally change the company's trajectory.
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in recent trading sessions, indicating heightened investor interest and trading volume. This activity may reflect market sentiment or reactions to recent developments within the company or its sector. Investors are closely monitoring WOK's performance as it navigates current market conditions. Increased trading activity suggests moderate influence on market sentiment and potential short-term performance.
22 Dec
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in recent trading sessions. The company is experiencing heightened interest from investors, which may be attributed to various market dynamics and developments within the medical technology sector. This increased activity could influence WOK's stock performance and investor sentiment moving forward. Increased trading activity may moderately influence market sentiment and financial performance.
18 Dec
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in the market, indicating heightened trading activity and investor interest. This surge in activity may reflect broader market trends or specific developments related to the company, potentially influencing its stock performance and investor sentiment in the near term. Increased trading activity suggests a moderately noticeable influence on market sentiment and potential financial performance.
17 Dec
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in the market, indicating heightened trading activity and investor interest. This surge in activity may reflect broader market trends or specific developments related to the company, potentially influencing its stock performance and investor sentiment moving forward. Increased trading activity suggests a moderately noticeable influence on market sentiment and potential financial performance.
16 Dec
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in the market, indicating heightened trading activity and investor interest. This surge in activity may reflect recent developments or market sentiment surrounding the company, potentially influencing its stock performance and investor perceptions. The increased trading volume could be a response to various factors, including market trends or company-specific news. Increased trading activity suggests a moderate influence on market sentiment and potential financial performance.
15 Dec
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in the market, indicating heightened trading activity and investor interest. This surge in activity may reflect broader market trends or specific developments related to the company, potentially influencing its stock performance and investor sentiment moving forward. Increased trading activity suggests a moderately noticeable influence on market sentiment and potential financial performance.
12 Dec
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in recent trading sessions, reflecting heightened investor interest and trading volume. The company's stock performance is being closely monitored as market dynamics shift, potentially influencing its future trajectory. Increased trading activity may affect market sentiment and investor interest, but it is not expected to fundamentally alter the company's long-term prospects.
11 Dec
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in recent trading sessions. The company's stock performance has garnered attention, reflecting fluctuations in market interest and investor sentiment. Analysts are closely monitoring WOK's developments as it navigates the competitive landscape of medical technology. The increased trading activity may indicate potential shifts in market dynamics or investor confidence in the company's future prospects. Increased trading activity suggests moderate influence on market sentiment and potential financial performance.
10 Dec
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in recent trading sessions, indicating heightened investor interest and trading volume. This activity may reflect market sentiment or reactions to recent developments related to the company or its sector. Investors are closely monitoring WOK's performance as it could signal potential opportunities or risks in the medical technology market. Increased trading activity suggests a moderate influence on market sentiment and potential short-term performance.
21 Oct
WORK Medical Technology Group LTD has announced a US$1 million equity investment in Neologics Bioscience, aiming to enhance its portfolio and expand its market presence in the medical technology sector. The investment may influence product innovation and competitive positioning but is not expected to drastically alter the company's overall trajectory.
16 Oct
WORK Medical Technology Group LTD announced a 1-for-100 reverse stock split effective October 21, 2025. This move is aimed at increasing the company's stock price and improving its market perception. The reverse split will reduce the number of outstanding shares, potentially making the stock more attractive to investors. The reverse stock split may influence market perception and stock price but does not fundamentally change the company's operations or long-term strategy.
14 Oct
WORK Medical Technology Group LTD has received a delisting determination letter from Nasdaq due to its failure to meet the exchange's minimum bid price requirement. The company has a 180-day period to regain compliance by achieving a minimum closing bid price of $1.00 for ten consecutive trading days. If compliance is not met, the company may appeal the decision or consider other options. The delisting notice may affect investor sentiment and operational focus, but the company has options to address the situation.
10 Oct
WORK Medical Technology Group LTD has been granted an additional 180-day period by Nasdaq to regain compliance with its listing requirements. This extension allows the company more time to meet the necessary criteria for maintaining its stock listing on the exchange. The extension provides WORK Medical Technology Group LTD with a crucial opportunity to stabilize its operations and potentially improve its market position.
6 Oct
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in recent trading sessions, reflecting heightened investor interest and market activity. The company's stock performance has drawn attention, indicating potential shifts in market dynamics and investor sentiment towards its operations and future prospects. Increased trading activity suggests a moderate influence on market sentiment and potential financial performance.
3 Oct
WORK Medical Technology Group LTD (WOK) has been identified as one of the most active stocks in recent trading sessions, indicating heightened investor interest and trading volume. This activity may reflect market sentiment towards the company's performance and future prospects, although specific details regarding the reasons for this increased activity were not provided. Increased trading activity suggests moderate influence on market sentiment and potential financial performance.
26 Sep
Univest Securities, LLC has successfully closed a registered direct offering for WORK Medical Technology Group LTD, raising $2.9 million. The offering is expected to enhance WORK's financial position and support its growth initiatives. The capital raised may moderately influence WORK's financial performance and growth strategies.
25 Sep
WORK Medical Technology Group LTD has announced the pricing of a registered direct offering amounting to $2.9 million. The offering is expected to enhance the company's financial position and support its growth initiatives. The shares will be sold at a price of $0.50 each, with the offering expected to close shortly, subject to customary closing conditions. The registered direct offering may provide necessary capital for growth but is not expected to fundamentally alter the company's trajectory.
23 Sep
WORK Medical Technology Group LTD has partnered with Xin Rui Hospital to develop healthcare AI applications. This collaboration aims to enhance medical services and improve patient outcomes through advanced technology integration. The partnership is expected to leverage both organizations' expertise in healthcare and technology, potentially leading to innovative solutions in the medical field. The partnership with Xin Rui Hospital represents a significant strategic move that could enhance WORK Medical's competitive positioning and market presence in healthcare technology.
22 Sep
WORK Medical Technology Group LTD has partnered with the Wuxi Branch of Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, to develop AI applications in healthcare. This collaboration aims to enhance healthcare services through innovative technology solutions, potentially improving patient outcomes and operational efficiencies. The partnership with a prestigious medical institution for AI development is likely to significantly enhance product innovation and competitive positioning.
22 May
Univest Securities, LLC announced the closing of a $5 million registered offering for WORK Medical Technology Group LTD (NASDAQ: WOK). The offering involved the sale of 10,000,000 ordinary units at $0.50 each, consisting of Class A ordinary shares and warrants. The gross proceeds will support the company's operations as a supplier of medical devices in China. The offering was conducted under a registration statement filed with the SEC. Univest acted as the sole book-running manager. The offering provides significant funding that may enhance WORK Medical Technology Group's operational capabilities and market presence.